The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Westwood Holdings Group Inc.

Westwood Holdings Group Inc. lifted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 9.6% during the 2nd quarter, HoldingsChannel reports. The fund owned 201,651 shares of the medical device company’s stock after acquiring an additional 17,639 shares during the period. Westwood Holdings Group Inc.’s holdings in Cooper Companies were worth $17,604,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of COO. Vanguard Group Inc. raised its holdings in Cooper Companies by 303.0% in the first quarter. Vanguard Group Inc. now owns 23,099,975 shares of the medical device company’s stock valued at $2,343,723,000 after buying an additional 17,367,502 shares during the period. Capital World Investors raised its position in Cooper Companies by 301.7% in the first quarter. Capital World Investors now owns 5,654,023 shares of the medical device company’s stock valued at $573,657,000 after purchasing an additional 4,246,519 shares during the period. Janus Henderson Group PLC lifted its stake in shares of Cooper Companies by 279.8% during the first quarter. Janus Henderson Group PLC now owns 3,437,064 shares of the medical device company’s stock worth $348,723,000 after purchasing an additional 2,532,186 shares in the last quarter. Impax Asset Management Group plc grew its stake in shares of Cooper Companies by 31.0% in the second quarter. Impax Asset Management Group plc now owns 2,359,798 shares of the medical device company’s stock valued at $205,511,000 after buying an additional 558,886 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in shares of Cooper Companies by 305.2% during the 1st quarter. Bessemer Group Inc. now owns 2,000,910 shares of the medical device company’s stock valued at $203,013,000 after buying an additional 1,507,049 shares during the period. 24.39% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cooper Companies

In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total transaction of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares of the company’s stock, valued at approximately $520,488.54. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of Cooper Companies stock in a transaction on Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares in the company, valued at $520,488.54. The disclosure for this sale can be found here. Over the last three months, insiders sold 256,373 shares of company stock worth $27,637,427. Company insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

Several brokerages have issued reports on COO. Piper Sandler increased their price objective on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research report on Thursday, August 29th. Stifel Nicolaus reaffirmed a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird boosted their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Wells Fargo & Company raised their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research note on Thursday, August 29th. Four investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, Cooper Companies has a consensus rating of “Moderate Buy” and an average target price of $115.00.

Cooper Companies Trading Down 0.5 %

Shares of NASDAQ COO opened at $110.49 on Friday. The company has a market cap of $22.00 billion, a price-to-earnings ratio of 64.99, a price-to-earnings-growth ratio of 2.60 and a beta of 0.98. The stock’s 50 day simple moving average is $97.93 and its 200 day simple moving average is $95.50. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a 12-month low of $75.93 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same quarter last year, the company earned $0.84 EPS. The company’s revenue for the quarter was up 7.8% compared to the same quarter last year. Equities research analysts expect that The Cooper Companies, Inc. will post 3.66 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.